Stephen Gardiner
Overview
Explore the profile of Stephen Gardiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ocampo A, Hatami F, cuklina J, Graham G, Ganjgahi H, Sun Y, et al.
Mult Scler
. 2024 Sep;
30(11-12):1455-1467.
PMID: 39340359
Background: The long-term disease trajectory of people living with multiple sclerosis (MS) can be improved by initiating efficacious treatment early. More quantitative evidence is needed on factors that affect a...
2.
Falck F, Zhu X, Ghalebikesabi S, Kormaksson M, Vandemeulebroecke M, Zhang C, et al.
J Biomed Inform
. 2024 Apr;
154:104641.
PMID: 38642627
Objective: Clinical trials involve the collection of a wealth of data, comprising multiple diverse measurements performed at baseline and follow-up visits over the course of a trial. The most common...
3.
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background
Zhang C, Shestopaloff K, Hollis B, Kwok C, Hon C, Hartmann N, et al.
Am J Hum Genet
. 2023 Sep;
110(10):1817-1824.
PMID: 37659414
Response to the anti-IL17 monoclonal antibody secukinumab is heterogeneous, and not all participants respond to treatment. Understanding whether this heterogeneity is driven by genetic variation is a key aim of...
4.
Mallon A, Haring D, Dahlke F, Aarden P, Afyouni S, Delbarre D, et al.
BMC Med Res Methodol
. 2021 Nov;
21(1):250.
PMID: 34773974
Background: Novartis and the University of Oxford's Big Data Institute (BDI) have established a research alliance with the aim to improve health care and drug development by making it more...
5.
Dahlke F, Arnold D, Aarden P, Ganjgahi H, Haring D, cuklina J, et al.
Mult Scler
. 2021 Jan;
27(13):2062-2076.
PMID: 33507835
Background: The Oxford Big Data Institute, multiple sclerosis (MS) physicians and Novartis aim to address unresolved questions in MS with a novel comprehensive clinical trial data set. Objective: The objective...
6.